Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?

Published:2014-10 Issue:5 Volume:23 Page:670-675
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kim Jiyoung,Kim Minkook,Lee Jun Ho,Lee Hyunchul,Lee Se Kyung,Bae Soo Youn,Jun Si-Youl,Kil Won Ho,Lee Jeong Eon,Kim Seok Won,Nam Seok Jin

Funder

Korea Healthcare Technology R&D Project

Ministry for Health & Welfare Affairs, Republic of Korea

Samsung Biomedical Research Institute

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference37 articles.

1. Breast cancer before age 40 years;Anders;Semin Oncol,2009

2. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression;Anders;J Clin Oncol,2008

3. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?;Aebi;Lancet,2000

4. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer;Walshe;J Clin Oncol,2006

5. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study;Petrek;J Clin Oncol,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the premature ovarian failure caused by cisplatin therapy;Frontiers in Oncology;2023-11-20

2. Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy;World Journal of Clinical Cases;2023-09-26

3. Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?;Clinical Medicine Insights: Reproductive Health;2019-01

4. Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy;Clinical Breast Cancer;2018-10

5. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis;Reproductive Sciences;2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3